Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Family Medicine | Nursing | Allergy | Journal

Back to Journal Articles

Impact of Cutaneous Lupus on Quality of Life Evaluated

Last Updated: June 29, 2012.

 

Cutaneous lupus erythematosus found to have similar negative impact for patients from two centers

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Cutaneous lupus erythematosus similarly negatively impacts quality of life among patients treated at two different centers, according to a study published online June 18 in the British Journal of Dermatology.

FRIDAY, June 29 (HealthDay News) -- Cutaneous lupus erythematosus (CLE) similarly negatively impacts quality of life among patients treated at two different centers, according to a study published online June 18 in the British Journal of Dermatology.

Noting that a study at the University of Pennsylvania Medical Center (UPenn) in Philadelphia demonstrated that quality of life is negatively impacted in CLE patients, Rebecca Vasquez, M.D., from the University of Texas Southwestern Medical Center (UTSW) in Dallas, and colleagues conducted surveys relating to quality of life among patients with CLE at UTSW (91 participants) and UPenn (157 participants).

The researchers found that most scores on the Skindex-29+3 and Short Form 36 (SF-36) surveys were similar between the two groups of patients. Compared to UPenn patients, UTSW patients were significantly more affected in the functioning and lupus-specific domains of the Skindex-29+3 and in the physical functioning, role-physical, and general health SF-36 subscales. Gender, income, education, presence of systemic lupus erythematosus, and skin disease activity were associated with poor quality of life in the UTSW patients.

"Differences in a minority of subdomains were likely attributed to variations in psychosocial behavior, presence of systemic lupus erythematosus, and gender," the authors write. "The combined quality-of-life data [strengthen] the notion that CLE patients are among the most severely impaired in terms of quality of life when compared with other common dermatologic and medical conditions."

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Biophysical Abnormalities Seen in Aorta of Obese Children Next: Survivorship of Uncemented Acetabular Parts Compared

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.